The GSDME gene helps damaged cells break apart and die when they can no longer function normally. If this process is altered, some cells may send stronger inflammation signals, and in the inner ear it can damage the tiny sensory cells needed for hearing. Certain variants in the GSDME gene are linked to inherited hearing loss, often beginning with trouble hearing high pitched sounds and slowly progressing. The gene is also being studied in cancer research because it may influence how some tumors respond to treatment.
What is a gene?
Genes are stretches of DNA that provide cells with instructions to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly direct when certain processes occur, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
GSDMEGene function
What if the gene works
The GSDME gene helps damaged cells die in a controlled way. This supports normal tissue health by clearing cells that are no longer working properly.
Risk
What if the gene does not work
Some variants in the GSDME gene are linked to inherited hearing loss, often starting after speech develops and ranging from mild to profound. Milder and more severe variants can affect when hearing changes start and how much hearing is affected.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the GSDME gene is currently established in clinical guidelines. The GSDME gene is being studied in cancer research as a biomarker and possible treatment target because it can influence inflammatory cell death.
Conditions associated with GSDME
Gene function
What if the gene works
The GSDME gene helps your body remove certain cells that have reached the end of their useful life. Its protein acts near the final stage of programmed cell death, creating small openings that let the process finish and send cleanup signals. Understanding how the GSDME gene works helps explain how tissues stay balanced over time.
The GSDME gene helps some cells complete programmed cell death when they are too damaged or no longer needed. This supports normal tissue upkeep and helps the body clear cells in a controlled way.
Its protein can make tiny openings in the cell membrane after it is switched on during cell death. These openings let the dying cell break down as part of a normal final step.
As these openings form, signals from the dying cell can spread into nearby tissue. This helps the immune system notice cell damage and take part in cleanup.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the GSDME gene, the variants most clearly linked to disease do not simply switch the protein off. They often make an abnormally short protein that leaves its pore-forming section exposed, which can trigger extra cell death. This is central to how variants in the GSDME gene affect protein function. Milder variants may have little effect, while more disruptive variants usually have a stronger impact and are linked to earlier or more pronounced hearing loss.
How variants are linked to conditions
Pathogenic variants in the GSDME gene cause a form of inherited hearing loss called autosomal dominant nonsyndromic hearing loss, often referred to as DFNA5-related hearing loss. In many families, this hearing loss starts after speech develops and gradually worsens over time. The link between GSDME gene variants and hearing loss is well established, and a disease-causing variant can confirm the diagnosis in the right clinical setting.
A variant is not necessarily a diagnosis
Human biology naturally includes genetic variants, and they are widespread in the general population. Most of these variants do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In other cases, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited hearing loss linked to the GSDME gene, the main driver is the gene change itself rather than lifestyle. Hearing can still be affected by other factors, so repeated loud-noise exposure and certain medicines that can harm hearing may worsen day-to-day hearing problems, but there is not enough evidence to say they change the underlying genetic risk.
Inheritance of GSDME variants
For families asking how GSDME variants are inherited, the best-established pattern is autosomal dominant for GSDME-related hearing loss. This means a parent with the disease-causing variant can pass it to a child with a 50% chance in each pregnancy. Mothers and fathers can both pass it on, and sons and daughters are affected with similar frequency. A person who inherits the variant may develop hearing loss, although the age it begins and how it progresses can vary between family members.
What does my GSDME result mean for my family?
A disease-causing change in the GSDME gene is most often linked to a dominantly inherited form of hearing loss, so close relatives such as parents, brothers, sisters, and children may also carry the same change. For many families, this means others may have hearing loss already or may develop it over time, sometimes starting later in life. Family testing can help clarify who else may be affected.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to inherited hearing loss, GSDME genetic testing usually analyzes a blood or saliva sample. A lab reads the GSDME gene to check for variants and may also look for missing or extra pieces. Results can show whether a GSDME variant helps explain hearing loss or runs in a family.
When should I consider getting a genetic test?
Genetic testing for the GSDME gene may be worth considering if hearing loss runs in your family, especially when it starts gradually and worsens over time. A harmful change in GSDME can confirm an inherited cause of certain kinds of hearing loss and help clarify the chances for close relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the kind of variant involved. Many other factors also influence how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how a person responds to medicines. Two people can take the same drug at the same dose, yet one may get more benefit while the other may have less effect or more side effects. This happens because inherited differences can change how the body breaks down, moves, or responds to a medicine. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can shape the way a person responds to medicines. It examines gene and drug patterns to help explain why the same treatment may affect people in different ways. With many medications, genes can influence either how powerfully a drug works or how the body handles it. This information can support treatment choices that are better informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the GSDME gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or treatment concerns are best discussed with your doctor. Researchers are studying GSDME because it may affect how some cells respond to certain cancer treatments, but this is not part of routine prescribing today.
History
Researchers first connected the GSDME gene to inherited hearing loss in the late 1990s, when families with a form of progressive deafness helped pinpoint a region on chromosome 7. Initially understood only through visible traits, later recognized as tied to a specific gene, it was first widely known by the name DFNA5. As medical science evolved, so did understanding of this gene. In the years that followed, scientists found that GSDME belongs to the gasdermin family, which shifted attention from hearing alone to broader cell biology. Interest grew further when studies linked altered GSDME activity to how cells break apart during certain forms of cell death, making it relevant in cancer research as well as hearing genetics.